- News Home
27 November 2013 12:59 pm ,
Vol. 342 ,
Science has exposed a thriving academic black market in China involving shady agencies, corrupt scientists, and...
Paper-selling agencies flourish in the aura of reputable businesses. For some scientists, it may be difficult to tell...
The new head of the National Center for Science Education promises to "fight the good fight" against attacks on...
Analyses of the H7N9 strains isolated from four new cases show that the virus is evolving rapidly, heightening anxiety...
In 2009, Jack Szostak shared a Nobel Prize for his part in discovering the role of telomeres, the end bits of...
Featuring the first lunar rover in 40 years, Chang'e-3 is seen as an important milestone on China's quest to send a...
Data collected by satellites and floating probes have chronicled a 2-decade rise in the temperature and thickness of a...
Cholesterol, the artery-clogging molecule that contributes to cardiovascular disease, has another nasty trick up its...
- 27 November 2013 12:59 pm , Vol. 342 , #6162
- About Us
Hat in Hand, Specter Proposes New Agency to Race for the Cure
27 April 2009 1:46 am
Senator Arlen Specter (R-PA) says giving the U.S. National Institutes of Health billions more dollars isn't enough to bolster biomedical research. On Saturday at a clinical research meeting in Chicago, he proposed a new independent agency to move bench discoveries to the bedside. And he wants your money to help him keep his seat.
Specter led a push to give NIH $10.4 billion in the recent stimulus package. He's now drafted a bill to be introduced this week that would authorize NIH to receive that funding as part of its base budget, bringing the total to $40 billion.
He explains his plan at a Web site, specterforthecure.com, that also urges visitors to contribute to his election campaign—he's facing a difficult primary battle to hold onto his seat in 2010. The bill would also create what he calls the Cures Acceleration Network, an independent federal agency, funded at $2 billion a year, that would attempt to bridge the so-called valley of death between discovering a potential drug and testing it in patients.
The agency's aim would be to "turn discoveries in biomedical research into better health for the American people," said Specter, a two-time cancer survivor. Biotech companies, universities, and patient groups could all apply for the grants, Specter said.
At least one prominent scientist thinks the network is a great idea. Former National Human Genome Research Institute Director Francis Collins, who was at the same meeting, told ScienceInsider that Specter's proposal is a "bold step" and that "the medical community should ... line up and try to figure out how to make it happen."